Prime Medicine, Inc.

PRME

NASDAQ

Healthcare

Biotechnology

Cambridge, MA, US214 employeesprimemedicine.com

$3.31

-0.08(-2.36%)

Mkt Cap $598M

$1.15

$6.67

52-Week Range

At A Glance

Prime Medicine, Inc., a biotechnology company, delivers genetic therapies to address diseases by deploying gene editing technology.

Revenue is primarily driven by Reportable Segment (100%).

Most recently: of this Current Report on Form 8-K, including Exhibit 99.1 attached hereto, is intended to be furnished and shall not be deemed “filed” for purposes of Section (2026-03-03).

$598M

Market Cap

$6M

Revenue

-$244M

Net Income

Employees214

Fundamentals

How The Business Makes Money

Revenue by Segment

Reportable Segment100%($8M)

Activity

What Changed Recently

Financial Results

Mar 2, 2026

of this Current Report on Form 8-K, including Exhibit 99.1 attached hereto, is intended to be furnished and shall not be deemed “filed” for purposes of Section

Regulation FD

Jan 11, 2026

, including Exhibit 99.1 attached hereto, is intended to be furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act

Peer Companies

Company	Price	Change	Market Cap	P/E
TYRATyra Biosciences, Inc.	$39.38	+2.89%	$2.1B	-18.1
VIRVir Biotechnology, Inc.	$9.04	+0.28%	$1.4B	-2.8
BCAXBicara Therapeutics Inc. ...	$21.48	+4.78%	$1.2B	-8.3
SEPNSepterna, Inc.	$25.20	+3.43%	$1.1B	-21.5
EYPTEyePoint Pharmaceuticals,...	$13.41	+3.00%	$1.1B	-4.6
MRVIMaravai LifeSciences Hold...	$2.96	+2.96%	$812M	-3.4
KURAKura Oncology, Inc.	$8.62	+3.36%	$761M	-2.6
REPLReplimune Group, Inc.	$8.27	+8.61%	$682M	-2.0

Analyst View

Company Profile

CIK0001894562

ISINUS74168J1016

CUSIP74168J101

Phone617-564-0013

Address21 Erie Street, Cambridge, MA, 02139, US

SEC EDGAR